Registry of Lobbyists
Version 1 of 2 (2005-10-13 to 2006-04-03) was submitted prior to the Lobbying Act coming into force on July 2, 2008. Due to different information requirements at that time, the registration is presented in the following format.
| Corporation: |
Wyeth Canada
50 Minthorn Blvd Markham, ON L3t 7Y2 Canada |
| Telephone number: | 905-470-3600 Ext.: 3954 |
| Fax number: | 905-470-3861 |
| Responsible officer name and position during the period of this registration: | Arnout Ploos van Amstel, President & Managing Director |
| Description of activities: | Wyeth is one of the world's largest research-based pharmaceutical and health care products comanies. It is a leader in the discovery development, manufacturing and marketing of prescription drugs and over-the-counter medications. It is also a leader in vaccines biotechnology and animal health care. |
| Parent: | The corporation is not a subsidiary of any other parent corporations. |
| Coalition | The corporation is not a member of a coalition. |
| Subsidiary: | The corporation does not have any subsidiaries that could be affected by the outcome of the undertaking. |
| Other direct interests | The corporation's activities are not controlled or directed by another individual, organization or corporation with a direct interest in the outcome of this undertaking. |
| Was the corporation funded in whole or in part by any domestic or foreign government institution in the last completed financial year? | No |
| Name: | Craig Martin |
| Position title: | VP, Corporate & Government Affairs |
| Public offices held: | No |
| Name: | Theodora Samiotis |
| Position title: | Director, Federal Affairs |
| Public offices held: | No |
| Federal departments or organizations which have been or will be communicated with during the course of the undertaking: | Health Canada (HC), Industry Canada, Patented Medicine Prices Review Board (PMPRB) | ||||||
|
Communication techniques that have been used or are expected to be used in the course of the undertaking:
|
Informal communications, Meetings, Presentations, Telephone calls, Written communications, whether in hard copy or electronic format | ||||||
| Subject Matter: Areas of Concern: | Health, Industry, Intellectual Property, International Relations | ||||||
| Subject Matter: Retrospective: | Internet Pharmacy,Cross-border trade,Industry policy re-pharmaceuticals | ||||||
| Subject Matter: Prospective: | Federal patent policy,Internet Pharmacy,Cross-border trade,Industry policy re-pharmaceuticals | ||||||
Details Regarding the Identified Subject Matter
|
|||||||